Malaria RDT - Artemisinin Therapy Applications

Three-line result differentiates P.f (HRP2+) requiring ACT vs P.v (pLDH+) requiring primaquine radical cure.

Field clinics prevent primaquine G6PD hemolysis in P.f mono-infection preventing relapses.

15-minute heat-stable test supports mass screening eliminating microscopy requirements.

HRP2 deletion monitoring prevents false negative reporting.